Objective: There is renewed scientific interest in the potential of plant-derived agents for the treatment of diabetes mellitus. This study investigated the antidiabetic actions of Swertia chirayita, a plant used traditionally in the management of diabetes.
Methods: Insulin secretion from BRIN-DB11 cells was assessed in the absence or presence of plant extract and modulators of beta cell function. Glucose uptake was assessed using 3T3-L1 cells while effects of the plant extract on protein glycation was assessed using model peptide. Insulin was measured by radioimmunoassay and intracellular calcium by FlexStation®.
Results: Swertia chirayita significantly stimulated concentration-dependent insulin secretion from BRIN-BD11 cells. Its insulinotropic effects were abolished in the absence of extracellular calcium or by diazoxide and were significantly decreased by verapamil and in beta cell depolarization with KCl. S.chirayita extracts evoked a 28-59% increase in basal and insulin-stimulated glucose uptake by 3T3-L1 cells. Protein glycation was significantly inhibited by S.chirayita in a dose-dependent manner.
Conclusion: This study reveals that the antidiabetic actions of S.chirayita aqueous bark extracts involves the stimulation of insulin secretion and enhancement of insulin action. Inhibition of protein glycation may also help counter diabetic complications. These actions of S.chirayita may provide new opportunities for the treatment of diabetes.
Insulin action, protein glycation, Swertia chirayita, type 2 diabetes